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care by medical staff and compliance by
patients. Additionally, monitoring has sec-
ondary benefits; it reinforces the risks asso-
ciated with warfarin, and it provides further
opportunities to educate the patient.
Rick Guthmann, MD, Advocate Illinois Masonic
Medical Center
What are the causes 
of hypomagnesemia? 
■ EVIDENCE-BASED ANSWER
The causes of magnesium depletion and hypo-
magnesemia are decreased gastrointestinal
(GI) absorption and increased renal loss.
Decreased GI absorption is frequently due 
to diarrhea, malabsorption, and inadequate
dietary intake. Common causes of excessive
urinary loss are diuresis due to alcohol, glyco-
suria, and loop diuretics. 
Medical conditions putting persons at high
risk for hypomagnesemia are alcoholism, con-
gestive heart failure, diabetes, chronic diarrhea,
hypokalemia, hypocalcemia, and malnutrition
(strength of recommendation: C, based on
expert opinion, physiology, and case series).
Evidence suggests that magnesium deficiency
is both more common and more clinically 
significant than generally appreciated. 
■ EVIDENCE SUMMARY 
Prevalence and incidence. In general, studies
are limited by variations in analytic techniques
and differences in defining the lower limit for
normal serum magnesium.1 Estimates of the
prevalence of hypomagnesemia in the general
population range from 2.5% to 15%. A study of
11,000 white urban Americans aged 45 to 64
years (probability sampling) found 2.5% with
magnesium <0.7 mmol/L and 5% with magne-
sium <0.75 mmol/L; rates for 4000 African
Americans were twice as high.2
Some authors have proposed a higher range
for normal serum magnesium, asserting that
dietary magnesium deficiency is endemic in
developed countries where acid rain reduces the
magnesium content of crops and food processing
causes further large reductions in the magne-
sium content of the diet.1 Moreover, common dis-
eases are associated with hypomagnesemia and
likely contaminate studies of “normal” popula-
tions. Thus, a study of 16,000 German subjects
(including blood donors, outpatients, and chil-
dren) found a 14.5% prevalence of hypomagne-
semia using a lower limit of 0.76 mmol/L1; how-
ever, applying the more commonly cited lower
limit of 0.70 mmol/L (1.7 mg/dL) to the same
data yielded a prevalence of 2%.
Numerous studies agree that the prevalence
of hypomagnesemia is much higher (10%–65%)
in subpopulations defined by severity of illness
(hospitalization, in intensive care unit [ICU] or
pediatric ICU), increasing age (elderly/in nurs-
ing home), or specific diseases. For example, of
94 consecutive patients admitted to the ICU,
65% had hypomagnesemia.3 Likewise, for 127
consecutive patients admitted with a diagnosis
of alcoholism, the prevalence was 30%.4
Because of limitations noted above, as well
as the lack of control groups, the relative
prevalence in these groups (compared with the
general population) is uncertain, but the stud-
ies do identify high-risk populations. A single
study, which included a control group, demon-
strated an 11% prevalence of hypomagnesemia
among 621 randomly selected hospitalized
patients compared with 2.5% among 341 hospi-
tal employees.5 Other diseases associated with
a high prevalence of hypomagnesemia include
cardiovascular disease (hypertension, conges-
tive heart failure, coronary artery disease), 
diabetes, diarrhea, diuretics use, hypokalemia,
hypocalcemia, and malabsorption.6–9
Common causes. We found no high-quality
studies to establish the relative probabilities of
various causes in the general population or any
subpopulation.10 The most common causes of
significant hypomagnesemia in developed coun-
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tries are said to be diabetes, alcoholism, and
the use of diuretics. In a group of 5100 consec-
utive patients (predominantly outpatient, 
middle-aged, and female) presenting to a diag-
nostic lab, the most common diagnoses associ-
ated with hypomagnesemia were diabetes (20%
of cases) and diuretic use (14% of cases); 
however, other potential causes, including 
alcoholism, were not identified.11 A complete
list of causes is in the Table.
Serious causes. A critical serum magnesium
level is less than 0.5 mmol/L and is associated
with seizures and life-threatening arrhythmias.6
Very low magnesium levels typically result
when an acute problem is superimposed on
chronic depletion. For example, critical levels
can occur among patients with diabetes during
correction of ketoacidosis or alcoholics who
develop vomiting, diarrhea, or pancreatitis. 
Magnesium in the 0.5 to 0.7 mmol/L range
may be life-threatening in certain disease 
contexts, such as acute myocardial infarction 
or congestive heart failure, where there is
already a risk of fatal arrhythmia.8
Impact. The impact of hypomagnesemia 
is underestimated largely because clinicians 
fail to measure magnesium.12 Since magnesium
is a cofactor for more than 300 enzymes and 
is involved in numerous transport mechanisms,
it is not surprising that hypomagnesemia is
associated with significant morbidity. 
For example, in a study of 381 consecutive
admissions at an inner-city hospital,13 approxi-
mately half the admissions went to ICUs and
half to regular wards. Despite similar Acute
Physiology and Chronic Health Evaluator
(APACHE) scores at admission, hospital mor-
tality was twice as high for hypomagnesemic
patients in both care settings.
■ RECOMMENDATIONS FROM
OTHERS
Several review articles include a compre-
hensive differential diagnosis for causes of
Causes of hypomagnesemia
Gastrointestinal
Diarrhea, dietary deficiency (including protein-calorie malnutrition, parenteral and enteral feeding 
with inadequate magnesium, alcoholism, and pregnancy), familial magnesium malabsorption, 
gastrointestinal fistulas, inflammatory bowel disease, laxative abuse, malabsorption (sprue, 
steatorrhea, chronic pancreatitis), nasogastric suction, surgical resection, vomiting
Renal
Alcoholism, diabetes, diuretics (thiazide, loop, and osmotic/hyperglycemia), other medications, 
hormones (hypoparathyroidism, hyperthyroidism, hyperaldosteronism, SIADH (syndrome of 
inappropriate antidiuretic hormone secretion), excessive vitamin D, ketoacidosis, renal disease 
(acute tubular necrosis, interstitial nephritis, glomerulonephritis, post-obstructive diuresis, post-renal
transplantation), hypercalcemia/hypophosphatemia, tubular defects (primary magnesium wasting,
Welt’s syndrome, Gitelman’s syndrome, renal tubular acidosis)
Shifts from extracellular to intracellular fluid
Acidosis (correction of), blood transfusions (massive), epinephrine, hungry bone syndrome, 
insulin/glucose/refeeding syndrome, pancreatitis (acute)
Transdermal losses
Excessive sweating, massive burns
TA B L E
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magnesium deficiency based on physiologic
principles as listed in the Table, but none 
provide data on the relative frequency of the
various causes in the general population or 
specific subgroups.6–9
David R. Mouw, MD, PhD, Robyn A. Latessa, MD,
University of North Carolina, MAHEC Family Practice
Residency, Asheville, NC; Elaine J. Sullo, MLS, 
East Carolina University, Laupus Library, Greenville, NC
■ CLINICAL COMMENTARY
We need to know when magnesium
replacement improves patient outcomes
Treating the underlying cause of hypomagne-
semia makes sense. However, even though cli-
nicians often treat “the numbers,” it is not clear
that magnesium replacement therapy is benefi-
cial in the absence of symptoms caused by the
hypomagnesemia. For example, hypomagne-
semia is common for patients with acute
myocardial infarction, but magnesium replace-
ment therapy has not been shown to improve
outcomes in 2 large randomized trials, the
Fourth International Study of Infarct Survival
(ISIS 4)14 and Magnesium in Coronaries
(MAGIC).15 We need better-designed random-
ized trials to know for what clinical conditions
magnesium replacement leads to improved
patient-oriented outcomes. 
John Hickner, MD, MSc, Department of Family
Medicine, The University of Chicago Pritzker School 
of Medicine, Chicago, Ill
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What are effective therapies
for Clostridium difficile–
associated diarrhea?
■ EVIDENCE-BASED ANSWER
Oral metronidazole and oral vancomycin are
equally effective treatments for Clostridium dif-
ficile–associated diarrhea (CDAD) (strength of
recommendation [SOR]: A, based on random-
ized trials). Oral vancomycin is considerably
more expensive and may select for colonization
with vancomycin-resistant enterococci, leading
the American College of Gastroenterology to
recommend oral metronidazole as preferred
therapy (SOR: C, expert opinion). They recom-
mend therapy with vancomycin for those who
are pregnant, breast feeding, less than 10
